Literature DB >> 26440192

Effect of surgical castration with or without oral meloxicam on the acute inflammatory response in yearling beef bulls.

S L Roberts, H D Hughes, N C Burdick Sanchez, J A Carroll, J G Powell, D S Hubbell, J T Richeson.   

Abstract

Pain management and welfare are increasingly prevalent concerns within animal agriculture. Analgesics may alleviate pain and inflammation associated with castration of beef cattle. This study was conducted to elucidate the effects of surgical castration on the acute inflammatory response and immunomodulation and whether concurrent oral administration of meloxicam (1 mg/kg BW) would alter these responses. On d -1, crossbred bull calves ( = 30; initial BW = 227.4 ± 10.3 kg) were fitted with indwelling jugular catheters and rectal temperature (RT) recording devices, placed into individual stanchions, and randomly assigned to 1 of 3 treatments. Treatment application occurred at h 0 and consisted of 1) intact bull calves treated with sham castration (CON), 2) bulls surgically castrated without meloxicam administration (CAS), and 3) bulls surgically castrated with oral meloxicam (1 mg/kg BW) administration (MEL). Blood samples were collected at 0.5-h intervals from h -2 to 4, 1.0-h intervals from h 4 to 8, and 12-h intervals from h 12 to 72. Serum was analyzed for cortisol and haptoglobin (Hp) concentrations using ELISA. Whole blood was analyzed for complete blood counts at -2, 0, 2, 4, 6, 8, 12, 24, 36, 48, 60, and 72 h, and RT was recorded in 5-min intervals. Postcastration RT was greatest for MEL (39.04), intermediate for CAS (38.99), and least for CON (38.93°C; ≤ 0.01). Serum cortisol was increased ( < 0.001) for CAS (12.3) and MEL (11.3) compared with CON (6.7 ng/mL) during the postcastration period. At 0.5 and 1.5 h, cortisol concentration was greater in CAS and MEL than CON, whereas at 2 and 2.5 h, cortisol concentration was greatest for CAS, intermediate for MEL, and least for CON (treatment × time, < 0.001). Total white blood cell ( ≤ 0.04), lymphocyte ( ≤ 0.02), and monocyte ( ≤ 0.002) counts were greatest for CAS, intermediate for MEL, and least for CON. Administration of MEL reduced ( ≤ 0.002) eosinophil counts during the postcastration period when compared with CON and CAS. The change in serum Hp, relative to baseline values, was reduced for MEL at 36 ( < 0.01) and 60 h ( ≤ 0.03), and the overall Hp concentration was least for MEL ( < 0.001). Oral administration of meloxicam at the time of castration reduced the acute inflammatory response in castrates, as evidenced by a reduction in Hp and certain leukocyte concentrations; it also caused a delayed increase in RT. Further research is needed to determine if this reduced acute inflammatory response would equate to improved health and/or performance after castration.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26440192     DOI: 10.2527/jas.2015-9160

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  13 in total

1.  Zinc injection as a novel castration method in beef bulls: effects on performance, behavior, and testosterone and haptoglobin concentration.

Authors:  Jase J Ball; Elizabeth B Kegley; Ty E Lawrence; Shelby L Roberts; Jeremy G Powell; John T Richeson
Journal:  J Anim Sci       Date:  2018-04-03       Impact factor: 3.159

2.  Effect of timing of subcutaneous meloxicam administration on indicators of pain after knife castration of weaned calves.

Authors:  D M Meléndez; S Marti; E A Pajor; D Moya; D Gellatly; E D Janzen; K S Schwartzkopf-Genswein
Journal:  J Anim Sci       Date:  2017-12       Impact factor: 3.159

3.  Effect of castration method and analgesia on inflammation, behavior, growth performance, and carcass traits in feedlot cattle.

Authors:  S L Roberts; J G Powell; H D Hughes; J T Richeson
Journal:  J Anim Sci       Date:  2018-02-15       Impact factor: 3.159

4.  Adverse effects of a 10-day course of ibuprofen in Holstein calves.

Authors:  P Walsh; F R Carvallo Chaigneau; M Anderson; N Behrens; H McEligot; B Gunnarson; L J Gershwin
Journal:  J Vet Pharmacol Ther       Date:  2016-02-14       Impact factor: 1.786

5.  Effect of a single dose of meloxicam prior to band or knife castration in 1-wk-old beef calves: I. Acute pain.

Authors:  D M Meléndez; S Marti; E A Pajor; D Moya; D Gellatly; E D Janzen; K S Schwartzkopf-Genswein
Journal:  J Anim Sci       Date:  2018-04-14       Impact factor: 3.159

6.  Effect of subcutaneous meloxicam on indicators of acute pain and distress after castration and branding in 2-mo-old beef calves1,2.

Authors:  Daniela M Meléndez; Sonia Marti; Ed A Pajor; Diego Moya; Désirée Gellatly; Eugene D Janzen; Karen S Schwartzkopf-Genswein
Journal:  J Anim Sci       Date:  2018-09-07       Impact factor: 3.159

7.  Effect of a single dose of subcutaneous meloxicam prior to band or knife castration in 1-wk-old beef calves: II. Inflammatory response and healing.

Authors:  Sonia Marti; Daniela M Meléndez; Ed A Pajor; Diego Moya; Desiree Gellatly; Eugene D Janzen; Karen S Schwartzkopf-Genswein
Journal:  J Anim Sci       Date:  2018-09-29       Impact factor: 3.159

8.  Non-Steroidal Anti-Inflammatory Drugs: Pharmacokinetics and Mitigation of Procedural-Pain in Cattle.

Authors:  Brooklyn K Wagner; Emma Nixon; Ivelisse Robles; Ronald E Baynes; Johann F Coetzee; Monique D Pairis-Garcia
Journal:  Animals (Basel)       Date:  2021-01-22       Impact factor: 2.752

9.  Effect of meloxicam and lidocaine administered alone or in combination on indicators of pain and distress during and after knife castration in weaned beef calves.

Authors:  Daniela M Meléndez; Sonia Marti; Edmond A Pajor; Pritam K Sidhu; Désirée Gellatly; Diego Moya; Eugene D Janzen; Johann F Coetzee; Karen S Schwartzkopf-Genswein
Journal:  PLoS One       Date:  2018-11-30       Impact factor: 3.240

10.  Clinical efficacy and pharmacokinetics of meloxicam in Mediterranean buffalo calves (Bubalus bubalis).

Authors:  Petra Cagnardi; Jacopo Guccione; Roberto Villa; Luigi D'Andrea; Antonio Di Loria; Maria Carmela Ferrante; Giuliano Borriello; Luigi Zicarelli; Paolo Ciaramella
Journal:  PLoS One       Date:  2017-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.